 Table S1, 
Supplemental experimental procedures Protein expression and purification
The catalytic domain (Ile16-Glu244 in the chymotrypsin template numbering) of human uPA was expressed in and purified from Pichia pastoris yeast strain X-33 (Zhao, et al., 2007) . Alternatively, we used full length human uPA purchased from PROSPEC, Israel. Indistinguishable results were obtained with uPA from the two sources. Both wild-type and mutated human PAI-1 were expressed in E. coli BL21 (DE3) cells, using the expression vector of pET-11d. Recombinant stable mutant PAI-1-14-1B (Berkenpas, et al., 1995) was expressed in E. coli C41 (DE3) cells, using pT7-PL as expression vector.
The cells were lysed by sonication and cleared by centrifugation in buffer A (50 mM MES, pH 6.1, 1 M NaCl). The hexa-His-tagged PAI-1 in the supernatant was subsequently purified by nickel column (Ni-NTA, Qiagen) chromatography and further purified on a Superdex-75 HR 10/30 column (Pharmacia) in buffer A. The protein was finally concentrated to 5 mg/ml and stored in aliquot at -70 o C. A panel of PAI-1 mutants was generated by overlap extension PCR, using the template of pET-11d-wt-PAI-1. The following five amino acid residues were chosen for substitution by alanine: Tyr-79, Thr-94, Asp-95, Ser-119 and His-143, based on the solved crystal structure. All mutations were confirmed by DNA sequencing, and the proteins were expressed and purified similarly to wild type PAI-1. Reactive centre-cleaved PAI-1-14-1B was prepared as described (Jensen and Gettins, 2008) . Latent wt PAI-1 was produced by incubating 10 μM wt PAI-1 sample for more than 24 hours at 37°C in 20 mM HEPES, pH 7.4, 150 mM NaCl. Full conversion to the latent state was verified by the absence of a uPA:PAI-1 band on SDS-PAGE, following incubation with molar excess of uPA. The human PAI-2 CD-loop, a variant with improved expression yield but unaffected uPA inhibition, (kindly provided by Marie
Ranson, University of Wollongong, Australia) was expressed in M15 cells and purified according to a published method (Cochran, et al., 2009 ). Rat PN-1 was a gift from Denis Monard, Friedrich Mischer Institute, Basel, Switzerland.
Fluorescence spectroscopy ligand binding assay
Fluorescence measurements were performed on a PTI Quantamaster instrument, equipped 
Supplemental Data
Supplemental Table   Table S1 . Values in parentheses are for highest resolution shell. a R merge =Σ|I i -<I>|/ΣI i , where I i is the intensity of the i th observation and <I> is the mean intensity of the reflections. b R work =Σ|F o -F c | /Σ|F o |, where F o and F c are the observed and calculated structure factor, respectively. c R free was calculated using 5% of data excluded from refinement. Figure S1 . Embelin inhibits the PAI-1-tPA complex formation. 4 µM PAI-1 was pre-incubated with vehicle or Embelin (50,100, 200 µM) in assay buffer for 10 min, followed by the addition of 2 µM tPA.
Supplemental Figures
After 15 min reaction at 37℃, samples were analyzed by reducing SDS-PAGE. The arrow with the dashed line denotes the cleaved form of PAI-1. The right panel shows the differences of PAI-1/PAI-2 residues in the region near embelin binding.
